| Direct Competitor Comparison | |
|---|
| HLF | PVT1 | PVT2 | PVT3 | Industry |
|---|
| Market Cap: | 4.91B | N/A | N/A | N/A | N/A |
|---|
| Employees: | 6,200 | 20,0001 | 13,5002 | N/A | N/A |
|---|
| Qtrly Rev Growth (yoy): | 0.17 | N/A | N/A | N/A | 0.00 |
|---|
| Revenue (ttm):
| 4.23B | 10.90B1 | 3.00B2 | N/A | N/A |
|---|
| Gross Margin (ttm): | 0.47 | N/A | N/A | N/A | 0.00 |
|---|
| EBITDA (ttm): | 753.02M | N/A | N/A | N/A | N/A |
|---|
| Operating Margin (ttm):
| 0.16 | N/A | N/A | N/A | 0.00 |
|---|
| Net Income (ttm): | 487.88M | N/A | 146.50M2 | N/A | N/A |
|---|
| EPS (ttm): | 4.28 | N/A | N/A | N/A | N/A |
|---|
| P/E (ttm): | 11.15 | N/A | N/A | N/A | N/A |
|---|
| PEG (5 yr expected): | 0.67 | N/A | N/A | N/A | N/A |
|---|
| P/S (ttm): | 1.17 | N/A | N/A | N/A | N/A |
|---|
|
| Pvt1 = Alticor Inc. (privately held) | | Pvt2 = NBTY, Inc. (privately held) | | Pvt3 = Shaklee Corporation (privately held) | | Industry = Drug Related Products | | 1 = As of 2011 2 = As of 2012 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.91 | 0.00 | 79.43B | 17.93 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 235.24 | 0.01 | 55.84B | 37.33 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.81 | 0.01 | 85.13B | 31.25 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 74.04 | 0.00 | 12.74B | 31.35 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.34 | -0.00 | 33.52B | 19.64 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.23 | -0.01 | 16.25B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.17 | -0.02 | 11.88B | 20.82 |
|---|
| Pfizer Inc. | PFE | 29.04 | -0.00 | 205.99B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.87B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.97 | 0.00 | 128.29B | 19.36 |
|---|
| Sanofi | SNY | 54.86 | 0.01 | 145.20B | 27.04 |
|---|
| Novartis AG | NVS | 74.36 | 0.01 | 182.72B | 18.87 |
|---|
| Roche Holding AG | RHHBY | 65.96 | 0.01 | 223.86B | 22.07 |
|---|
| AstraZeneca PLC | AZN | 52.17 | 0.00 | 65.21B | 11.54 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.86B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.40 | 0.01 | 77.86B | 53.68 |
|---|
|
| News on Direct Competitors | |
|---|
No Direct Competitor ComparisionCurrency in USD. | |
|
0.60(1.24%) May 24, 4:03PM EDT|After Hours
:
47.65 0.00 (0.00%) May 24, 5:52PM EDT